Phase III clinical study of levo-alpha-acetylmethadol.
D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004347:Drug Interactions; D004644:Emotions; D005260:Female; D005500:Follow-Up Studies; D006556:Heroin Dependence / Q000534:rehabilitation*; D006801:Humans; D013287:Illicit Drugs / Q000008:administration & dosage; D008297:Male; D008691:Methadone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008692:Methadyl Acetate / Q000009:adverse effects / Q000627:therapeutic use*; D011247:Pregnancy; D012107:Research Design; D012646:Self Administration; D013375:Substance Withdrawal Syndrome / Q000517:prevention & control
D013287:Illicit Drugs; D008692:Methadyl Acetate; D008691:Methadone